Laxness’s realignment bolsters Q2 ebitda, as sales decline

Specialty chemicals manufacturer Laxness has reported net income down 13.8 per cent to E75 million in the second quarter of 2016, on sales that decreased by 7.7 per cent to E1.94 billion.